COVID - 19: Clinical Trials

43 trials for COVID - 19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 6 recruiting, 5 active not recruiting, 3 not yet recruiting. 6 Not applicable, 6 Phase 1, 5 Phase 2, 3 Early Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Enrolling by invitation 1, Recruiting 1
Phase 16Completed 4, Active not recruiting 2
Phase 25Completed 2, Recruiting 2, Withdrawn 1
Early Phase 13Completed 2, Not yet recruiting 1
Phase 32Not yet recruiting 1, Unknown 1
Phase 41Recruiting 1

Follow COVID - 19: new trials by email Literature Review of COVID - 19 trials Research Report on COVID - 19

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dapagliflozin for Long COVID Syndrome
Dapagliflozin (DAPA), Placebo - COVID - 19, Long COVID Syndrome
Phase 3Not yet recruitingOttawa Heart Institute Research Corporation1922026-12-012026-10-30
Effect of Surgical Masks in Preventing Acute Respiratory Infections
Surgical masks - Acute Respiratory Infections (ARIs), Influenza
Not applicableEnrolling by invitationChiba University24002026-07-312026-09-23
Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France
saliva sampling, Nasopharyngeal swab - Respiratory Tract Infections (RTI), Influenza -Like Illness
RecruitingInstitut National de la Santé Et de la Recherche Médicale, France250002026-05-142026-08-03
Development of Preterm Infants Born During the COVID-19 Pandemic
Evaluation of cognitive and psychomotor development through the Bayley Scales Of Infant and Toddler Development and Wechsler Preschool and Primary Scale of Intelligence - Preterm Infant Development, COVID - 19
Not yet recruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1202026-05-012026-05-11
Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
COVID-19 Vaccines - COVID - 19, SARS CoV-2
Phase 1Active not recruitingRokote Laboratories Finland Oy202026-02-102026-07-22
A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults
GC4006A, Normal Saline - COVID - 19
Phase 1Active not recruitingGC Biopharma Corp722026-01-282026-07-27
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Pfizer-BioNTech mRNA COVID-19 vaccine, Novavax recombinant protein vaccine - COVID -19, COVID - 19
Phase 4RecruitingHenry M. Jackson Foundation for the Advancement of Military Medicine542025-11-122026-10-28
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
Ratutrelvir (83-0060) non-randomised, Paxlovid, Ratutrelvir (83-0060) - COVID - 19
Phase 2RecruitingTraws Pharma, Inc.902025-09-162026-01-21
Perioperative Outcomes for Children With Preoperative URTI Symptoms After COVID-19 Pandemic
URTI, Postoperative Complications
Completedaijun xu23922025-09-012025-11-21
Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Remdesivir (RDV) - COVID - 19, Renal Transplant
Phase 2RecruitingFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia152025-09-012025-09-29
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms
Respimer® Hygiene-Prevention -Baby, kids, adults, Respimer® Hygiene-Prevention Kids, adults, Respimer® Decongestion Baby, kids, adults - URTI, Bronchiolitis
Not applicableRecruitingLaboratoire de la Mer10652025-08-272025-12-03
Impact of Covid-19 on Syphilis
Patients diagnosed with syphilis - Syphilis, COVID - 19
Active not recruitingAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria2402025-05-282025-09-02
Surveillance, Assessment and Detection of Influenza Associated Respiratory Infections in HIV Positive and Negative Individual in Lusaka, Zambia.
Influenza, RSV
RecruitingCentre for Infectious Disease Research in Zambia5942025-05-202026-08-05
EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL
Colchicine 0.5 MG Oral Tablet - COVID - 19
Phase 1 / Phase 2CompletedZaeema Kanwal662025-02-242025-09-04
Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
KFD1(0µg ), KFD1(20µg), KFD1(40µg) - COVID - 19
Early Phase 1Not yet recruitingShanghai Public Health Clinical Center602024-12-302025-01-10
Covid Flu A/B and RSV 4 in 1 Diagnostic Test
Investigational Flu A/B Covid-19 and RSV Diagnostic Test - Influenza A, Influenza B
CompletediHealth Labs inc11192024-11-152026-01-08
Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test
Investigational Flu A/B And Covid-19 Diagnostic Test - COVID - 19, Influenza A
CompletediHealth Labs inc5882024-11-122026-01-08
Retail COVID-19 Study
FDA approved mRNA vaccines - COVID - 19
CompletedBiomedical Advanced Research and Development Authority25192024-10-192026-05-22
COVID-19 Infection and Thoracic Anesthesia?
Prehabilitation, No postponement - COVID - 19, Thoracic Anesthesia
CompletedAnkara University1102024-09-122025-08-12
The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients
COVID - 19, Prognosis
CompletedAnkara University1462024-09-012025-11-24

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

COVID-19 (43)  ·  Influenza, Human (6)  ·  Coronavirus Infections (2)  ·  Post-Acute COVID-19 Syndrome (2)  ·  Respiratory Syncytial Virus Infections (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acute Lung Injury (1)  ·  Ageusia (1)  ·  Anosmia (1)  ·  Anxiety Disorders (1)  ·  Behavior (1)  ·  Bronchiolitis (1)  ·  Coitus (1)

Broader conditions

Coronaviridae Infections (43)  ·  Infections (43)  ·  Lung Diseases (43)  ·  Nidovirales Infections (43)  ·  Pneumonia (43)  ·  RNA Virus Infections (43)  ·  Respiratory Tract Diseases (43)  ·  Pneumonia, Viral (42)  ·  Coronavirus Infections (41)  ·  Respiratory Tract Infections (41)  ·  Virus Diseases (41)  ·  Orthomyxoviridae Infections (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Pathologic Processes (5)  ·  Immune System Diseases (4)

Interventions

COVID-19 Vaccines (1)  ·  Colchicine (1)  ·  Eicosapentaenoic Acid (1)  ·  Fatty Acids, Omega-3 (1)  ·  Hearing Tests (1)  ·  Hydroxychloroquine (1)  ·  Preoperative Exercise (1)  ·  Prone Position (1)  ·  Safety (1)  ·  Saline Solution (1)  ·  Surveys and Questionnaires (1)  ·  Tablets (1)  ·  camostat (1)  ·  dapagliflozin (1)  ·  nirmatrelvir and ritonavir drug combination (1)

Sponsors

Ankara University (2)  ·  iHealth Labs inc (2)  ·  Alexandria University (1)  ·  Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria (1)  ·  Biomedical Advanced Research and Development Authority (1)  ·  Centre Hospitalier Universitaire de la Guadeloupe (1)  ·  Centre for Infectious Disease Research in Zambia (1)  ·  Chiba University (1)  ·  Duke University (1)  ·  Fayoum University (1)  ·  Federal University of Minas Gerais (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1)  ·  GC Biopharma Corp (1)

Countries

United States (7)  ·  Turkey (Türkiye) (5)  ·  Italy (4)  ·  Canada (3)  ·  France (3)  ·  China (2)  ·  Egypt (2)  ·  Puerto Rico (2)  ·  South Korea (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Brazil (1)  ·  Estonia (1)  ·  Finland (1)  ·  Guadeloupe (1)

Top investigators

Andres M Salazar, MD (1)  ·  Edward Mitre, MD (1)  ·  Emily M D'Agostino, DPH, MS, MEd, MA (1)  ·  Masato Murakami, MD (1)  ·  Paolo Gionchetti, MD (1)  ·  Perseus Missirlis, MD, MSc (1)  ·  Ricardo T Gazzinelli, DVM, PhD (1)  ·  Sarunyou Chusri, M.D., Ph.D. (1)  ·  Suzy Duflo, MD PhD (1)

Results publications

PMID 10377201, PMID 110688, PMID 11440640, PMID 12668799, PMID 14715035, PMID 16011702, PMID 16051812, PMID 16625202, PMID 18073382, PMID 18778201, PMID 19355966, PMID 19420084, PMID 19564349, PMID 20038196, PMID 20389020, PMID 20549206, PMID 20590838, PMID 20615924, PMID 21467219, PMID 22065672, PMID 22086194, PMID 22100537, PMID 22379685, PMID 23032745, PMID 25424847, PMID 26320841, PMID 26564103, PMID 26870818, PMID 27956136, PMID 28158275, PMID 29696308, PMID 30110645, PMID 30611774, PMID 31699709, PMID 31986264, PMID 32125452, PMID 32134116, PMID 32298247, PMID 32475821, PMID 32574262, PMID 32784198, PMID 32978920, PMID 32998157, PMID 33065795, PMID 33104290, PMID 33288947, PMID 33428867, PMID 33496163, PMID 33627138, PMID 33753937

NIH funding

U01MD018294 (1)